American College of Rheumatology Convergence (ACR)

Rheumatic Disease Patients Still Need Pandemic Treatment Counsel

A survey of 9,004 patients with rheumatic disease shows that patients may need continued medication counseling through the duration of the pandemic, finds a study due to be presented on Friday at the American College of Rheumatology.

Study Shows Denosumab Has Greater Impact on Bone Mineral Density Than Alendronate

January 14, 2021

The increase in spinal bone mineral density was significantly higher in patients treated with denosumab compared with alendronate after adjustment for bone mineral density at baseline, age, sex, and other osteoporosis risk factors.

Denosumab Was the Most Frequently Initiated Osteoporosis Drug in 2018, ACR Study Finds

January 06, 2021

The results of a study presented at ACR 2020 demonstrate that a greater proportion of patients were initiated on denosumab compared with bisphosphonates for the first time—18.5% compared with 16.9%— in 2018.

ACR 2020 Rewind: Conference Highlights and Expert Interviews

December 30, 2020

Catch up on the biggest studies and expert interviews from ACR 2020.

Reducing the Immunogenicity of Pegloticase in Patients With Refractory Gout

December 21, 2020

Puja Khanna MD, MPH, associate professor of medicine at the University of Michigan, discusses a presentation she gave at the American College of Rheumatology Convergence 2020 on reducing the immunogenicity of pegloticase and improving its efficacy.

SPIRIT-H2H: Ixekizumab as Efficacious as Adalimumab for Psoriatic Arthritis

December 16, 2020

Ixekizumab appears to provide significantly greater simultaneous joint and skin improvement for patients with psoriatic arthritis than adalimumab and doesn’t require combination with methotrexate to boost its efficacy.

Patient Perspectives in Lupus

December 04, 2020

In today's interview, our focus is on patient perspectives. During the American College of Rheumatology annual meeting last month, Juana Mata shared her story of a life living with lupus. Getting an accurate diagnosis wasn't easy, but eventually she found a doctor and treatment that's working for her. In today's interview, Kim Gorgens, a psychologist and Rheumatology Network board member interviews Juana and her sister, Estela, who describe turning a lupus diagnosis into a positive force for change through advocacy. The sisters have created a non-profit group called Looms for Lupus in which they embrace art therapy to relieve stress.

Stress Can Take Its Toll Rheumatic Disease

December 01, 2020

Anxiety and depression are not uncommon among lupus patients, show studies recently presented at the annual meeting of the American College of Rheumatology.

New Year May Bring New Lupus Treatments

November 13, 2020

At this year's annual meeting of the American College of Rheumatology, there were a number of studies presented on different treatments for lupus. It's an exciting time in lupus research says Dr. Richard Furie, chief of rheumatology at Northwell Health in New York. In today's one on one interview, he breaks down some of the lupus studies presented at the meeting

ACR Set to Issue Updated Treatment Guidelines

November 12, 2020

The American College of Rheumatology is expected to issue updated treatment guidelines for rheumatoid arthritis no later than spring 2021. The new guidelines will include recommended uses for biologics approved since the last update in 2015―including JAK inhibitors.

ACR Conference Roundup: New RA Treatment Guidelines Preview

November 12, 2020

In this week's news roundup from Rheumatology Network, we highlight studies presented at the annual meeting of the American College of Rheumatology, which wrapped this week. Among the stories we covered included a preview of the soon-to-be released rheumatoid arthritis guidelines, promising new treatments for lupus nephritis and advances in osteoporosis care. Learn more in today's news roundup.